Discover
TVGN
Tevogen Bio Holdings Inc.
5.74
2 x 4.71
2 x 7.61
bid
ask
+
0.08
1.41%
2 @ 04:00 PM
5.90 +0.16 (2.79%)
| Ytd | -65.32% | |
| 1y | -90.59% |
5.74
day range
6.75
4.13
52 week range
71.00
| Open | 6.01 | Prev Close | 5.66 | Low | 5.74 | High | 6.75 | Mkt Cap | 24.22M |
| Vol | 35.68K | Avg Vol | 29.62K | EPS | -6.44 | P/E | N/A | Forward P/E | N/A |
| Beta | -1.03 | Short Ratio | 0.09 | Inst. Own | 3.82% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 8.49 | 200-d Avg | 16.98 | 1yr Est | 4.20 |
| Income Statement | |||
| Operating Expenses | 5.40M | ||
| Research and Development Expense | 3.13M | ||
| Selling, General and Administrative Expense | 2.27M | ||
| Operating Income | -5.40M | ||
| Interest Expense | 71.17K | ||
| Net Income | -5.62M | ||
| Net Income Common Stock | -5.62M | ||
| Net Income Common Stock (USD) | -5.62M | ||
| Consolidated Income | -5.45M | ||
| Net Income to Non-Controlling Interests | 175.07K | ||
| Earnings per Basic Share | -1.61 | ||
| Earnings per Basic Share (USD) | -1.61 | ||
| Earnings per Diluted Share | -1.61 | ||
| Earning Before Interest & Taxes (EBIT) | -5.55M | ||
| Earning Before Interest & Taxes (USD) | -5.55M | ||
| Weighted Average Shares | 3.49M | ||
| Weighted Average Shares Diluted | 3.49M | ||
| Balance Sheet | |||
| Cash and Equivalents | 692.31K | ||
| Cash and Equivalents (USD) | 692.31K | ||
| Trade and Non-Trade Receivables | 158.82K | ||
| Current Assets | 2.14M | ||
| Property, Plant & Equipment Net | 1.53M | ||
| Total Assets | 4.92M | ||
| Debt Current | 1.98M | ||
| Total Debt | 9.47M | ||
| Current Liabilities | 7.27M | ||
| Debt Non-Current | 7.49M | ||
| Total Liabilities | 14.76M | ||
| Accumulated Retained Earnings (Deficit) | -145.11M | ||
| Shareholders Equity | -9.84M | ||
| Shareholders Equity (USD) | -9.84M | ||
| Assets Non-Current | 2.78M | ||
| Total Debt (USD) | 9.47M | ||
| Liabilities Non-Current | 7.49M | ||
| Trade and Non-Trade Payables | 4.05M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 59.05K | ||
| Net Cash Flow from Financing | 2.87M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 139.93K | ||
| Issuance (Purchase) of Equity Shares | 873.70K | ||
| Issuance (Repayment) of Debt Securities | 2.00M | ||
| Net Cash Flow from Operations | -2.73M | ||
| Share Based Compensation | 2.85M | ||